Differences in Ki67 Labeling Index between Primary and Synchronous Metastasis of Pancreatic Neuroendocrine Tumors (PanNETs): Implications on Daily Practice

被引:0
|
作者
Eren, Ozgur Can [1 ]
Esmer, Rohat [2 ]
Adsay, David [1 ]
Bagci, Pelin [3 ]
Tarcan, Zeynep [4 ]
Basturk, Olca [4 ]
Saka, Burcu [2 ]
机构
[1] Koc Univ, Istanbul, Turkiye
[2] Koc Univ, Sch Med, Istanbul, Turkiye
[3] Marmara Univ, Istanbul, Turkiye
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1460
引用
收藏
页码:S1827 / S1827
页数:1
相关论文
共 50 条
  • [31] Is Ki67 Index in Biopsy Tissue Truly Reflect Grading of Pancreatic Neuroendocrine Neoplasm?
    Gao, H.
    Jin, K.
    Wang, W.
    Zhang, S.
    Xu, J.
    Liu, L.
    Yu, X.
    NEUROENDOCRINOLOGY, 2017, 105 : 127 - 127
  • [32] An Objective Assessment of Ki67 Proliferative Index Quantification in Gastroenteropancreatic Neuroendocrine Tumors (NETs)
    Tang, L. H.
    Gonen, M.
    Hedvat, C.
    Modlin, I. M.
    Klimstra, D. S.
    MODERN PATHOLOGY, 2011, 24 : 170A - 170A
  • [33] An Objective Assessment of Ki67 Proliferative Index Quantification in Gastroenteropancreatic Neuroendocrine Tumors (NETs)
    Tang, L. H.
    Gonen, M.
    Hedvat, C.
    Modlin, I. M.
    Klimstra, D. S.
    LABORATORY INVESTIGATION, 2011, 91 : 170A - 170A
  • [34] The Ki67 index evaluation of pancreatic neuroendocrine tumors using 3D immunohistochemistry in small tissue specimens
    Ikeda, Eriko
    Shinozaki, Satoshi
    Sakaguchi, Mio
    Sano, Naoki
    Kabasawa, Shin
    Kanno, Atsushi
    Ando, Kozue
    Yokoyama, Kensuke
    Tamada, Kiichi
    Onodera, Hiroshi
    Yamamoto, Hironori
    Fukushima, Noriyoshi
    PANCREATOLOGY, 2023, 23 (05) : 537 - 542
  • [35] Digital image analysis of Ki67 heterogeneity of pancreatic neuroendocrine neoplasms with or without liver metastasis
    Zhang, M.
    Hang, X.
    Xu, M.
    Huang, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S76 - S76
  • [36] Distinctive grade based on Ki67 index and immune microenvironment of metastatic pancreatic neuroendocrine tumors responding to capecitabine plus temozolomide
    Gao, Heli
    Zhang, Wuhu
    Li, Zheng
    Liu, Wensheng
    Liu, Mengqi
    Zhuo, Qifeng
    Shi, Yihua
    Xu, Wenyan
    Zhou, Chenjie
    Qin, Yi
    Xu, Jin
    Chen, Jie
    Yu, Xianjun
    Xu, Xiaowu
    Ji, Shunrong
    BMC CANCER, 2024, 24 (01)
  • [37] Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate
    McCall, Chad M.
    Shi, Chanjuan
    Cornish, Toby C.
    Klimstra, David S.
    Tang, Laura H.
    Basturk, Olca
    Mun, Liew Jun
    Ellison, Trevor A.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Schulick, Richard D.
    Edil, Barish H.
    Hruban, Ralph H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (11) : 1671 - 1677
  • [38] Streptozotocin Based Chemotherapy in Advanced G2 Pancreatic Neuroendocrine Tumors (PNET): Efficacy According to Ki67 Index
    Jimenez-Fonseca, P.
    Carmona-Bayonas, A.
    Solis, M. P.
    Vieitez, J. M.
    Sanchez, M. L.
    Ruiz, A. L.
    Rodriguez, D.
    Faez, L.
    Li, W.
    Crespo, G.
    Castano, A.
    Garcia-Carbonero, R.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 119 - 120
  • [39] The Effect of Tumor Heterogeneity on the Prognostic Value of Ki67 Labeling Index in Well-Differentiated Neuroendocrine Tumors (NETs) Metastatic to the Liver
    Yang, Z.
    Tang, L. H.
    Klimstra, D. S.
    MODERN PATHOLOGY, 2010, 23 : 375A - 375A
  • [40] Longitudinal changes in Ki-67 index in a prospective cohort of pancreatic neuroendocrine tumors
    Mollazadegan, K.
    Botling, J.
    Welin, S.
    Zhang, L.
    Eriksson, B.
    Lase, I
    Sundin, A.
    Crona, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 146 - 146